Robert Michael
Verkställande Direktör på ABBVIE INC.
Förmögenhet: 25 M $ per 30.06.2025
Profil
Robert A. Michael currently works at AbbVie, Inc., as Chairman & Chief Executive Officer from 2025, Fremont Holding LLC, as Chief Executive Officer, Tobira Therapeutics, Inc., as Chief Executive Officer, Allergan UC, as President & Vice Chairman from 2020, AbbVie Biotherapeutics Ltd., as Director from 2019, and AbbVie Ltd. (United Kingdom), as President & Chief Operating Officer from 2022.
Mr. Michael also formerly worked at Allergan GI Corp., as President & Director and Abbott Laboratories, as Division Controller-Nutrition Supply Chain from 1993 to 2012.
Mr. Michael received his undergraduate degree from Kelley School of Business and Masters Business Admin degree from UCLA Anderson School of Management.
Kända innehav i offentliga företag
Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
---|---|---|---|---|
ABBVIE, INC. 0,01 % | 10.03.2025 | 132 821 ( 0,01 % ) | 25 M $ | 30.06.2025 |
Senaste nyheterna om Robert Michael
Aktiva positioner av Robert Michael
Företag | Position | Start |
---|---|---|
ABBVIE INC. | Verkställande Direktör | 01.07.2024 |
ALLERGAN PLC | President | 08.05.2020 |
TOBIRA THERAPEUTICS INC | Verkställande Direktör | - |
AbbVie Biotherapeutics Ltd.
![]() AbbVie Biotherapeutics Ltd. Financial ConglomeratesFinance Founded in 2016, AbbVie Biotherapeutics Ltd. is a British company that functions as an investment holding company. Part of AbbVie, Inc., the company is based in Maidenhead, UK. | Direktör/Styrelseledamot | 01.04.2019 |
Fremont Holding LLC
![]() Fremont Holding LLC Pharmaceuticals: MajorHealth Technology Fremont Holding LLC engages in provision of pharmaceutical services. The company is headquartered in North Chicago, IL. | Verkställande Direktör | - |
AbbVie Ltd. (United Kingdom)
![]() AbbVie Ltd. (United Kingdom) Miscellaneous Commercial ServicesCommercial Services Part of AbbVie, Inc., AbbVie Ltd. (United Kingdom) is a British company that develops advanced therapies through research and innovation. The company is based in Maidenhead, UK and was founded in 2012. | President | 01.01.2022 |
Tidigare kända positioner av Robert Michael
Företag | Position | Slut |
---|---|---|
ABBOTT LABORATORIES | Företagsledare/Principal | 01.08.2012 |
Allergan GI Corp.
![]() Allergan GI Corp. BiotechnologyHealth Technology Allergan GI Corp. develops peptide therapeutics for the treatment of gastrointestinal disorders. It provides RM-493 a small-peptide melanocortin-4 receptor agonist, for the treatment of obesity and diabetes, and RM-131 a small-peptide ghrelin agonist, for the treatment of diabetic gastro paresis and other gastrointestinal functional disorders. The company was founded by Bart Henderson and Elizabeth Stoner in 2008 and is headquartered in Madison, NJ. | President | - |
Utbildning av Robert Michael
Kelley School of Business | Undergraduate Degree |
UCLA Anderson School of Management | Masters Business Admin |
Erfarenheter
Innehade positioner
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
Börsnoterade företag | 2 |
---|---|
ABBVIE INC. | Health Technology |
ABBOTT LABORATORIES | Health Technology |
Privata företag | 6 |
---|---|
AbbVie Biotherapeutics Ltd.
![]() AbbVie Biotherapeutics Ltd. Financial ConglomeratesFinance Founded in 2016, AbbVie Biotherapeutics Ltd. is a British company that functions as an investment holding company. Part of AbbVie, Inc., the company is based in Maidenhead, UK. | Finance |
Fremont Holding LLC
![]() Fremont Holding LLC Pharmaceuticals: MajorHealth Technology Fremont Holding LLC engages in provision of pharmaceutical services. The company is headquartered in North Chicago, IL. | Health Technology |
Allergan Ltd. (Ireland)
![]() Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |
Tobira Therapeutics, Inc.
![]() Tobira Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tobira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The company was founded on September 11, 2006 and is headquartered in Madison, NJ. | Health Technology |
Allergan GI Corp.
![]() Allergan GI Corp. BiotechnologyHealth Technology Allergan GI Corp. develops peptide therapeutics for the treatment of gastrointestinal disorders. It provides RM-493 a small-peptide melanocortin-4 receptor agonist, for the treatment of obesity and diabetes, and RM-131 a small-peptide ghrelin agonist, for the treatment of diabetic gastro paresis and other gastrointestinal functional disorders. The company was founded by Bart Henderson and Elizabeth Stoner in 2008 and is headquartered in Madison, NJ. | Health Technology |
AbbVie Ltd. (United Kingdom)
![]() AbbVie Ltd. (United Kingdom) Miscellaneous Commercial ServicesCommercial Services Part of AbbVie, Inc., AbbVie Ltd. (United Kingdom) is a British company that develops advanced therapies through research and innovation. The company is based in Maidenhead, UK and was founded in 2012. | Commercial Services |